WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 984

Summary — HB 984: “Cannabis Treatment Research Act” (Regulate Research of Medical Cannabis)

Status & Procedural Notes
- Title: Regulate Research of Medical Cannabis (referred in text as the North Carolina Cannabis Treatment Research Act).
- Introduced: Filed Nov 12, 2024 (per docket).
- Early action: Read first time and referred to committee (Public Education) — status listed as “Passed 1st Reading.”
- The bill would add a new Article 5I to Chapter 90 of the North Carolina General Statutes (new sections beginning at G.S. 90‑113.160).

Purpose
- To create a statutory framework that permits and regulates clinical/research studies of cannabis as a medical treatment, while establishing registration, oversight, legal protections, and recordkeeping to support such research.

Key Provisions
1. Definitions and scope (G.S. 90‑113.161)
- “Cannabis” is defined consistent with existing marijuana statute (G.S. 90‑87) and, in some provisions, limited to quantities of 1.5 ounces or less.
- Defines “research institution,” “registered research study,” “written certification,” “patient,” “physician,” and “caregiver.”

  1. Expansion/amendment of existing exemption (amend G.S. 90‑94.1)

    • Replaces/revises prior “hemp extract” exemption to allow possession and use of cannabis by individuals who are participants in a registered cannabis research study, subject to limits set by the research institution.
    • Requires participants to carry required documentation (a physician’s written certification) and subjects possession to disposal rules for unused portions.

  2. Cannabis Treatment Research Database and registration (G.S. 90‑113.162)

    • DHHS must establish a secure electronic Cannabis Treatment Research database to register:
      • Research institutions conducting studies
      • Physicians
      • Caregivers (registration of caregivers is mandatory)
      • Patients participating in registered studies
    • Database contains caregiver/patient contact information and institutional details; institutions must update changes.

  3. Caregivers and written certification

    • Caregivers: NC residents age 18+ who are parent/guardian/custodian of patient and who hold a physician’s written certification documenting patient participation in a registered study.
    • Written certification: physician statement in medical record that potential benefits likely outweigh risks.

  4. Protections and confidentiality (G.S. 90‑113.163)

    • Research institutions and their employees are protected from arrest, prosecution, discipline, or denial of rights for conducting authorized cannabis research or providing required certifications.
    • Participant, caregiver, and institution identities submitted to DHHS are confidential and not public record; may be shared with law enforcement as authorized.

  5. Research program objectives and permissible activities (G.S. 90‑113.164)

    • Encourages scientific research on medical uses of cannabis including quality control, purity and labeling standards, best‑practice administration, and strain analysis to match strains to conditions.

  6. Dispensation from other jurisdictions

    • On a case‑by‑case basis, institutions may approve dispensing to registered caregivers cannabis acquired from outside the state — institutions must instruct on required secure disposal procedures.

Who Would Be Affected
- Patients diagnosed with qualifying medical conditions who enroll in registered cannabis research studies.
- Caregivers who are registered and authorized to possess/administer cannabis for enrolled patients.
- Physicians who issue written certifications and may participate in clinical research.
- Research institutions (hospitals, universities, labs, manufacturers, private research entities) registering to conduct studies.
- Department of Health and Human Services (to operate the registry) and law enforcement (authorized to verify registrations).
- Broader health‑regulatory and legal framework (potentially impacts prosecution policies, evidence handling, and public health administration).

Potential Impacts & Considerations
- Legal/administrative: Establishes an official research pathway that provides immunity and confidentiality protections; creates new DHHS registry responsibilities.
- Clinical and scientific: Facilitates controlled research on efficacy, safety, quality control, and strain‑specific effects — could inform future policy or broader medical access.
- Enforcement and oversight: Requires clear procedures for registration validation, safe dispensing, recordkeeping, and secure disposal of unused cannabis.
- No fiscal estimates included in the provided text; implementation would likely require DHHS administrative resources.

Selected statute sections added/affected: G.S. 90‑94.1 (amended) and new Article 5I (G.S. 90‑113.160–90‑113.164).

Primary sponsor listed in provided text: Representative Belk.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.